Affiliated Managers Group, Inc., through its affiliates, operates as an investment management company providing investment management services to mutual funds, institutional clients,retails and high net worth individuals in the United States. It provides advisory or sub-advisory services to mutual funds. These funds are distributed to retail, high net worth and institutional clients directly and through intermediaries, including independent investment advisors, retirement plan sponsors, broker-dealers, major fund marketplaces, and bank trust departments. The company also offers investment products in various investment styles in the institutional distribution channel, including small, small/mid, mid, and large capitalization value and growth equity, and emerging markets. In addition, it offers quantitative, alternative, and fixed income products, and manages assets for foundations and endowments, defined benefit, and defined contribution plans for corporations and municipalities. Affiliated Managers Group provides investment management or customized investment counseling and fiduciary services. Affiliated Managers Group, Inc. was formed in 1993 and is based in West Palm Beach, Florida with additional offices in Prides Crossing, Massachusetts; Stamford, Connecticut; London, United Kingdom; Dubai, United Arab Emirates; Sydney, Australia; Hong Kong; Tokyo, Japan, Zurich, Switzerland and Delaware.

Affiliated Managers Group Inc.

SilverCrest Asset Management ( ($SAMG) ) has issued an update. Silvercrest Asset Management Group Inc. announced on July 27, 2026, that it will hol...

SilverCrest Asset Management Schedules Q2 2026 Investor Call

AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) has issued an update. AMG Critical Materials N.V., a global supplier of critical materials and ad...

AMG Completes Full Acquisition of Zinnwald Lithium to Advance European Lithium Project

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has ended a late-stage study of rocatinlimab in prurigo nodularis...

Amgen Halts Key Phase 3 Rocatinlimab Study, Resetting Expectations in Dermatology

Bernstein analyst Courtney Breen maintained a Hold rating on Amgen yesterday and set a price target of $335.00. The company’s shares closed yesterd...

Bernstein Reaffirms Their Hold Rating on Amgen (AMGN)

AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) has provided an update. AMG Critical Materials N.V., a global supplier of critical materials and ...

AMG Secures $700 Million in New Credit Facilities to Extend Maturities and Boost Liquidity

AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) has issued an announcement. AMG Critical Materials N.V., a global supplier of critical materials ...

AMG Schedules Second-Quarter 2026 Results and Investor Call

MetalNRG Plc ( ($GB:AMG) ) has issued an announcement. Atlas Metals Group plc, a natural resources and energy company listed on the London Stock Ex...

Atlas Metals Raises New Equity to Cut Debt and Update Voting Rights

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has stopped a late stage study testing bemarituzumab in advanced ...

Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 1 trial that tests how its obesity d...

Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has halted a key Phase 3 maintenance study known as ROCKET-ASCEND...

Amgen’s Rocatinlimab Eczema Trial Termination Jolts Investor Expectations

Citi analyst Geoff Meacham maintained a Hold rating on Amgen today and set a price target of $345.00. Meacham covers the Healthcare sector, focusin...

Citi Sticks to Its Hold Rating for Amgen (AMGN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Denali Therapeutics (DNLI) and Amgen (AMGN). Denali Therapeutics ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Denali Therapeutics (DNLI) and Amgen (AMGN)

Bank of America Securities analyst Craig Siegenthaler maintained a Buy rating on Affiliated Managers yesterday. The company’s shares closed yesterd...

Bank of America Securities Reaffirms Their Buy Rating on Affiliated Managers (AMG)

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 2 study called “A Phase 2, Randomize...

Amgen’s Rocatinlimab Asthma Trial Reaches Phase 2 Finish Line

MetalNRG Plc ( ($GB:AMG) ) has shared an announcement. Atlas Metals Group plc has confirmed that as of 1 July 2026 its issued share capital consist...

Atlas Metals Confirms 43.9 Million Voting Shares for FCA Disclosure

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest study looks at how its obesity drug candidate works with rout...

Amgen’s AMG 133 Trial Adds a New Data Point in the Obesity Drug Race

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a new early-stage trial titled “An Open-Label, ...

Amgen Refines Its PCSK9 Franchise with New Evolocumab Bioavailability Study

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims &...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), BridgeBio Pharma (BBIO) and Jazz Pharm...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMG	$363.80	+1.54%	199.27K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AMG	$363.80	+1.5%	199.27K
3
4
5
6

AMG

AMG

Get Affiliated Managers Group Inc. Data in Excel

Get Affiliated Managers Group Inc. Data in Excel